| __timestamp | Amphastar Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 15635076 |
| Thursday, January 1, 2015 | 37065000 | 23943601 |
| Friday, January 1, 2016 | 41199000 | 23689111 |
| Sunday, January 1, 2017 | 43415000 | 41006114 |
| Monday, January 1, 2018 | 57564000 | 51379106 |
| Tuesday, January 1, 2019 | 68853000 | 32705593 |
| Wednesday, January 1, 2020 | 67229000 | 53274000 |
| Friday, January 1, 2021 | 60932000 | 85352000 |
| Saturday, January 1, 2022 | 74771000 | 51999000 |
| Sunday, January 1, 2023 | 73741000 | 59471000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Amphastar Pharmaceuticals, Inc. and Summit Therapeutics Inc. have demonstrated distinct strategies in their R&D allocations.
From 2014 to 2023, Amphastar Pharmaceuticals consistently increased its R&D expenses, peaking in 2022 with a 163% rise from its 2014 levels. This upward trend underscores Amphastar's dedication to expanding its research capabilities. Meanwhile, Summit Therapeutics showcased a more volatile pattern, with a notable surge in 2021, where R&D spending jumped by 445% compared to 2014. This spike highlights Summit's strategic pivot towards intensive research initiatives.
These trends reflect broader industry dynamics, where strategic R&D investments are pivotal for maintaining competitive advantage and driving future growth.
Pfizer Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Genmab A/S and Summit Therapeutics Inc.
Viatris Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Summit Therapeutics Inc. and Grifols, S.A.
Comparing Innovation Spending: Summit Therapeutics Inc. and Perrigo Company plc
Analyzing R&D Budgets: Summit Therapeutics Inc. vs Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for Ultragenyx Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.
R&D Spending Showdown: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Xenon Pharmaceuticals Inc. vs Amphastar Pharmaceuticals, Inc.
Comparing Innovation Spending: Wave Life Sciences Ltd. and Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds